Literature DB >> 34157816

Cardioprotective Effect of Marsdenia tenacissima and Sansevieria roxburghiana in Doxorubicin-induced Cardiotoxicity in Rats in vivo: The Role of Dresgenin and Lupeol

Aparna Ann Mathew1, Raju Asirvatham1, Dawn V Tomy1.   

Abstract

Objectives: The major adverse effect of doxorubicin (DOX) in cancer treatment is cardiac toxicity. Murva is a controversial plant used in the Ayurvedic system, which consist of more than 12 medicinal plant roots found in different parts of India. Marsdenia tenacissima (MT) is an acceptable source in Murva, whereas Sansevieria roxburghiana (SR) Schult & Schult.f. (S. zeylanica Roxb.) are also considered as Murva in West Bengal, India. The present study focused on the evaluation of the cardioprotective mechanism as well as the in vivo cardioprotective potential of methanol extracts of MT and SR on rats by using in silico methods. Materials and
Methods: A total of 48 rats were divided into 8 groups with 6 in each group. DOX 20 mg/kg, intraperitoneally (i.p.) was administered to all rats on the 13th day, with the exception of group 1. Group 2 was the disease control, group 3 was the treated with the standard drug propronolol, and groups 4 to 5 were treated with two lower doses of methanol extract of MT (MEMT) and methanol extract of SR (MESR), whereas group 7 received higher dose combinations of both extracts for 14 continuous days. Blood and tissue antioxidant levels as well as cardiac enzymes were measured at the end of the study. Damage to cellular functional units was analyzed by histopathological study. Dresgenin from MT similarly lupeol from SR were taken as ligands for the target peroxisome proliferator activated receptors (PPARα) protein to find out the mechanism of action. High-performance thin layer chromatography (HPTLC) fingerprinting was performed to determine the number of phytoconstituents present in both extracts.
Results: The combination that showed the most significant (p<0.001) effect on altered cardiac enzymes and antioxidant enzyme levels in both blood and tissues also corrected the extreme damage in cellular functional units. Dresgenin and lupeol showed binding scores of -8.2 (kcal/mol) and -9 (kcal/mol), respectively, with PPARα. HPTLC reports revealed that 17 and 12 peaks were found at 254 nm for dresgenin and lupeol, respectively.
Conclusion: The study results concluded that the combination of MESR and MEMT and that of MESR and MEMT exerted cardioprotective activity via binding of dresgenin and lupeol to PPARα. The order of efficacy was the extract combination > MESR > MEMT.

Entities:  

Keywords:  Doxorubicin; HPTLC; cardiac enzyme; cardioprotective; molecular docking

Year:  2021        PMID: 34157816      PMCID: PMC8231321          DOI: 10.4274/tjps.galenos.2020.27880

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  9 in total

1.  Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats.

Authors:  Gyas Khan; Syed Ehtaishamul Haque; Tarique Anwer; Mohd Neyaz Ahsan; Mohammad M Safhi; M F Alam
Journal:  Acta Pol Pharm       Date:  2014 Sep-Oct       Impact factor: 0.330

2.  Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.

Authors:  Muzaffar Iqbal; Kiran Dubey; Tarique Anwer; Agrawal Ashish; Krishna K Pillai
Journal:  Pharmacol Rep       Date:  2008 May-Jun       Impact factor: 3.024

Review 3.  An historical approach to the diagnostic biomarkers of acute coronary syndrome.

Authors:  Elisa Danese; Martina Montagnana
Journal:  Ann Transl Med       Date:  2016-05

4.  Computational protein-ligand docking and virtual drug screening with the AutoDock suite.

Authors:  Stefano Forli; Ruth Huey; Michael E Pique; Michel F Sanner; David S Goodsell; Arthur J Olson
Journal:  Nat Protoc       Date:  2016-04-14       Impact factor: 13.491

5.  Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.

Authors:  Murat Yagmurca; Ersin Fadillioglu; Hasan Erdogan; Muharrem Ucar; Sadik Sogut; M Kemal Irmak
Journal:  Pharmacol Res       Date:  2003-10       Impact factor: 7.658

6.  Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines.

Authors:  Syed Sikander Azam; Sumra Wajid Abbasi
Journal:  Theor Biol Med Model       Date:  2013-10-24       Impact factor: 2.432

Review 7.  Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.

Authors:  Wang-Soo Lee; Jaetaek Kim
Journal:  PPAR Res       Date:  2015-10-26       Impact factor: 4.964

Review 8.  Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress.

Authors:  Jorge G Farías; Víctor M Molina; Rodrigo A Carrasco; Andrea B Zepeda; Elías Figueroa; Pablo Letelier; Rodrigo L Castillo
Journal:  Nutrients       Date:  2017-09-01       Impact factor: 5.717

Review 9.  Anticancer drug discovery from Chinese medicinal herbs.

Authors:  Mu-Yang Huang; Le-Le Zhang; Jian Ding; Jin-Jian Lu
Journal:  Chin Med       Date:  2018-07-04       Impact factor: 5.455

  9 in total
  1 in total

Review 1.  Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Cardiovasc Toxicol       Date:  2022-01-24       Impact factor: 3.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.